A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ractopamine-D3 | CAS 1219908-63-0 - Request Quote

Picture of Ractopamine-D3

Ractopamine-D3

SZ CAT No:SZ-R066D02
CAS No
1219908-63-0
Mol.F.
C18H20D3NO3
Mol.Wt.
304.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ractopamine-D3 is chemically 4-(1-Hydroxy-2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl-1,2,2-d3)phenol. Ractopamine-D3 is supplied with detailed characterization data compliant with regulatory guideline. Ractopamine-D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ractopamine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1219908-63-0

Purchase 1219908-63-0

Order 1219908-63-0

Enquire 1219908-63-0

price of 1219908-63-0

1219908-63-0 Supplier

1219908-63-0 Manufacturer

1219908-63-0 Exporter

buy high quality Ractopamine-D3

Purchase Ractopamine-D3

Ractopamine-D3 suppliers

Ractopamine-D3 manufacturers

Ractopamine-D3 price

Order Ractopamine-D3

Enquire Ractopamine-D3

Ractopamine-D3 cost

Ractopamine-D3 Supplier

Ractopamine-D3 Distributor

Ractopamine-D3 for Method Validation

Ractopamine Reference Standard

Ractopamine-D3 for ANDA Filing

Ractopamine-D3 for Forced Degradation Studies

Ractopamine-D3 Identification Standards

Ractopamine-D3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,